# LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
Canonical URL: https://biopharmsignal.com/news/LENZ/lenz-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-and-recent-corporate-highlights-on-march-24-2026
Ticker: LENZ
Company: Lenz Therapeutics Inc
Source: Lenz Therapeutics Inc
Published: 2026-03-17 12:00 EST
Original Source URL: https://ir.lenz-tx.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-06 12:15 EST — [LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopia](https://biopharmsignal.com/news/LENZ/lenz-therapeutics-announces-launch-of-new-telehealth-prescribing-option-to-accel-e7f681dd) — Source: Lenz Therapeutics Inc
- 2026-06-24 12:30 EST — [LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand](https://biopharmsignal.com/news/LENZ/lenz-therapeutics-and-arrotex-pharmaceuticals-announce-exclusive-license-and-com-069a15c4) — Source: Lenz Therapeutics Inc
- 2026-06-07 23:30 EST — [LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China](https://biopharmsignal.com/news/LENZ/lenz-therapeutics-announces-everest-medicines-acquired-rights-to-develop-and-com-434c4009) — Source: Lenz Therapeutics Inc
- 2026-05-26 12:00 EST — [LENZ Therapeutics to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/LENZ/lenz-therapeutics-to-participate-in-upcoming-investor-conferences) — Source: Lenz Therapeutics Inc
- 2026-05-11 20:05 EST — [LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights](https://biopharmsignal.com/news/LENZ/lenz-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights) — Source: Lenz Therapeutics Inc
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)